ARIAD Pharmaceuticals, Inc. · Cambridge, MA United States (NASDAQ: ARIA)
| 26 Landsdowne St. | Phone: 617-494-0400 |
| Cambridge, MA | Fax: 617-494-8144 |
| 02139 | |
| United States | 
Map This Company |
ARIAD Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Biologics MfgCompany Description
ARIAD Pharmaceuticals is exploring the myriad possibilities for new cancer treatments. The firm has three lead drug candidates: ridaforolimus, ponatinib, and AP26113, each being studied for the treatment of various types of cancer. ARIAD is developing ridaforolimus with
ARIAD Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ARIA Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 122 |
Executives
39 executives listed for ARIAD Pharmaceuticals, Inc.'s Cambridge, MA location.
| Chairman, President, and CEO | Harvey Berger | |
|---|---|---|
| EVP, CFO, and Treasurer | Edward Fitzgerald | |
| SVP and Chief Intellectual Property Officer | David Berstein |